MedTrace Logo

Expression of CD19 Complex in Lymphoproliferative Disorders

NCT04734470 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 92

Last updated 2021-02-04

No results posted yet for this study

Summary

1. To study the expression pattern of CD19(cluster of differentiation antigen19) complex in lymphoproliferative disorders and its diagnostic value.
2. To investigate the biological significance of CD19 complex expression in lymphoproliferative disorders.
3. To explore the possibility of ectopic expression of CD19 complex in non B-lineage lymphoproliferative disorders.

Conditions

  • Lymphoproliferative Disorders

Interventions

DIAGNOSTIC_TEST

Flow cytometry

The study of CD19 complex expression in lymphoproliferative disorders by flowcytometry

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-31
Primary Completion
2023-03-31
Completion
2023-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04734470 on ClinicalTrials.gov